… the antiviral activities of remdesivir against SARS-CoV-2, the causative agent of COVID-19. …
A specific antiviral treatment for COVID-19 is yet to be identified; 14 therefore, several …

… -spectrum antiviral effects, and antiviral mechanism. In addition, the preclinical studies, antiviral
… to expand our knowledge on molnupiravir and better deal with the COVID-19 epidemic. …

… specific effective antiviral treatment for COVID-19. Although most of the COVID-19 patients
… In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for …

… severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2) … The current
COVID-19 emergency warrants the urgent … Notably, the drug shows antiviral activity in vitro against …

… antiviral properties. It also provides basic CP information relevant for planning and initiating
COVID-19 … (AZ) reduced viral load in coronavirus disease 2019 (COVID-19) patients. AZ was …

… safety, tolerability, and antiviral activity of molnupiravir dosed twice-daily for 5 days in the
treatment of patients with mild to moderate COVID-19. Hypotheses included that molnupiravir …

… COVID-19 and SARS are also similar in terms of transmission route and clinical characteristics,
while the currently reported mortality rate of COVID-19 is … syndrome coronavirus (MERS-…

… verified in vitro against both non-COVID and multiple coronaviruses. Molnupiravir has been
… its antiviral efficacy in persons infected with COVID-19. The medication displays antiviral …

… , including SARS coronavirus, is particularly important. With the COVID-19 emergency and
the urgent need for compounds to counteract the pandemic, the antiviral properties of GR and …

… antiviral activity, to be useful vaccine adjuvants and to have potential anti‐SARS‐CoV‐2
activity. … of chitosan and its derivatives as an antiviral agent and proposes a future application in …